Treatment FAQ

how much does malaria treatment cost in africa

by Carey Hilpert Published 3 years ago Updated 2 years ago
image

The economic cost ranged between US$9.14 and US$37.99 per episode of uncomplicated malaria at a median cost US$22.48. The study in Nigeria by Onwujekwe et al. [18], undertaken in selected public primary health facilities in a rural setting, estimated a provider cost of US$30 per outpatient malaria treatment.Apr 10, 2017

Is malaria treatment free in Africa?

Although malaria prevalence is decreasing and treatment is provided free of charge, households seeking treatment are confronted with out-of-pocket expenditures and lost working days; particularly in remote villages.Sep 16, 2021

How much does it cost to treat malaria in Nigeria?

Average amount charged patient for treating uncomplicated malaria in private hospitals was N3,941. Average amount spent on antimalarial drugs was about N2,443 (62%) while N1,064 (27.7%) was spent on laboratory investigation and N406. 00 (10.3%) for medical consultation.

How much would it cost to solve malaria?

Eradicating malaria by 2040 would cost between $90 billion and $120 billion, according to the Gates Foundation. The WHO says annual funding will need to reach [PDF] $6.4 billion per year, more than twice current levels, by 2020 to reduce global malaria incidence and mortality by 40 percent.Oct 5, 2016

How much does it cost to treat malaria in Kenya?

The mean health system cost per patient was Kenyan Shilling (KSh) 4288 (USD 42.0) (95% confidence interval (CI) 95% CI KSh 4046–4531). The total household cost per patient was KSh 1676 (USD 16.4) (95% CI KSh 1488–1864) and consisted of: KSh 161 (USD1.Oct 30, 2021

How much is a hospital stay in Nigeria?

between 30,000 and 100,000 NairaA hospital stay including one night in a single room costs between 30,000 and 100,000 Naira (£65-£218/$82-$275*). This includes the cost of treatment and medical examinations.

How much does malaria treatment cost in India?

The average cost of treating a patient with chloroquine worked out to Rs. 1068/- the cost of treating a patient with mefloquine worked out to Rs. 1188/- and the cost of treating a patient with co artemether worked out to Rs. 1051/- (excluding drug cost, since the drug is not marketed in India, Table 2).

Is malaria treatment expensive?

The median financial cost of diagnosing a case of malaria was $4.32 (range $0.34-$9.34). The median financial cost of treating an episode of uncomplicated malaria was $5.84 (range $2.36-$23.65) and the median financial cost of treating an episode of severe malaria was $30.26 (range $15.64-$137.87).Nov 3, 2011

How much is malaria treatment in Ghana?

The average direct medical cost of treating malaria was GH¢3.2 (US$2.1) per case with the insured spending less (GH¢2.6/US$1.7) per case than the uninsured (GH¢3.2/US$2.1). The overall average cost (direct and indirect) incurred by households per malaria treatment was GH¢20.9 (US$13.9).

How do you get rid of malaria in Africa?

These include accelerated investment and deployment of vaccines, new diagnostic tools, new funding strategies for malaria control and keeping in check the drug and insecticide resistance challenge. Funding is also key if African countries are going to move closer to eradication.Apr 24, 2017

Which is the best malaria drug in Kenya?

The national malaria control guidelines, recommend dihydroartemisinin-piperaquine as the second-line treatment for uncomplicated malaria in Kenya. The treatment recommendation for severe malaria is parenteral artesunate, while treatment with parenteral quinine is permitted in absence of artesunate.Dec 21, 2017

What is the most common antimalarial drug?

The most common antimalarial drugs include: Chloroquine phosphate. Chloroquine is the preferred treatment for any parasite that is sensitive to the drug. But in many parts of the world, parasites are resistant to chloroquine, and the drug is no longer an effective treatment.Oct 12, 2021

Do you need malaria tablets in Kenya?

CDC recommends that travelers going to certain areas of Kenya take prescription medicine to prevent malaria. Depending on the medicine you take, you will need to start taking this medicine multiple days before your trip, as well as during and after your trip.

How much does malaria cost?

These direct costs (for example, illness, treatment, premature death) have been estimated to be at least US$ 12 billion per year.

Where is malaria common?

Malaria and poverty are intimately connected. It is commonest in the poorest countries in the poorest continent, Africa. The only parts of Africa relatively free of malaria are the northern and southern extremes, which have the richest countries on the continent. Across the globe, some of the poorest countries in other continents also have ...

What is the number one reason for consultation in many countries across Africa?

Maintenance, supply and staffing of health facilities: Malaria is the number one reason for consultation in many countries across Africa. Its direct effect is the swelling of hospitals, clinics and health posts by patients who are on admission or are attending on an outpatient basis. This indirectly leads to greater pressure on facilities and available staff

Which country has the worst malaria?

Across the globe, some of the poorest countries in other continents also have a serious malaria problem, including India, the country with the greatest number of poor people in the world, and Haiti, the country that has the worst malaria in the Western Hemisphere, and it is the poorest country in the hemisphere.

Is fever considered malaria?

This means that the individual sometimes does not give malaria the attention it deserves. For example, fever is automatically considered as malaria, leading to self-medication and resulting sometimes in late presentation for adequate assessment and treatment.

How does the modelling approach help malaria?

The modelling approach enables results to be extrapolated from trials to operational settings , and the standardised analytical framework facilitates comparison of the cost-effectiveness of different malaria control interventions. The representation of the results as realistic ranges rather than simple point estimates incorporates much of the uncertainty surrounding the input parameters, and allows robust conclusions to be drawn from uncertain data. Nonetheless, although we stratified our results by economic and epidemiological zones where possible, substantial generalisation across areas was necessary, because of the lack of data.

How much does insecticide cost?

In a very-low-income country, for insecticide treatment of existing nets, the cost-effectiveness range was US$4–10 per DALY averted; for provision of nets and insecticide treatment $19–85; for residual spraying (two rounds per year) $32–58; for chemoprophylaxis for children $3–12 (assuming an existing delivery system); for intermittent treatment of pregnant women $4–29; and for improvement in case management $1–8. Although some interventions are inexpensive, achieving high coverage with an intervention to prevent childhood malaria would use a high proportion of current health-care expenditure.

Who initiated and coordinated the research and supervised all stages of the study?

Anne Mills initiated and coordinated the research and supervised all stages. Catherine Goodman and Paul Coleman reviewed the literature, designed the models, and did the analysis. All investigators contributed to the writing of the paper.

Who is Anne Mills?

This study was supported by the Global Forum for Health Research through a grant provided by the World Bank. Anne Mills and Catherine Goodman are members of the London School of Hygiene and Tropical Medicine Health Economics and Financing Programme, which is supported by the UK Department for International Development. This project was undertaken in collaboration with the London School of Hygiene and Tropical Medicine Malaria Programme and the London/Liverpool Malaria Consortium. We also thank the many researchers and control staff who provided technical advice.

Who is the Director General of WHO?

One of the main initiatives of Gro Harlem Brundtland, the new Director General of WHO, was to launch the Roll Back Malaria campaign, which aims to generate a substantial expansion in effective malaria prevention and treatment.

Where are nets distributed in Mali?

The Ministry of Health (MoH) provided free nets to pregnant women at their first ANC visit and to infants when they complete their national immunization series. Nets were distributed to health facilities within all regions of Mali. Because this process has been ongoing for an extended period, little refresher training or additional planning was necessary. Nets are stocked year-round in central storage warehouses in Bamako. Transportation of the ITNs to the health districts from central storage took place via road, on a semi-annual basis, using commercial haulers selected by the implementing partner. After the ITNs were delivered to the districts, the district health authorities were responsible for allocating the ITNs to the health facilities, based on requisition forms that health facilities submitted monthly. Typically, health facilities store a 3-month supply of nets; however, this varied depending on the facilities’ storage capacity and was, therefore, inconsistent across health facilities. While other health facility distributions programs often suspend distributions during mass distribution years, Mali’s health facility distributions continued operating in Bamako and Segou. CD utilized human resources at the district and health facility levels throughout the year. These personnel assisted with the transport, storage, and issuing of ITNs; supervision, planning, training, and data reporting. Health facility personnel retrieved nets from district warehouses and transported them (with fuel costs typically reimbursed by the district) to health facilities for storage and they provided nets to patients along with counselling and advice on ITN use as part of the ANC/EPI visit.

What is capital cost?

Capital costs are costs incurred to purchase goods or services with a life span longer than 1 year. Recurrent costs are costs incurred for goods or services lasting less than 1 year.

What is CD in health?

The World Health Organization recommends both large-scale mass distribution campaigns and continuous distributions (CD) as part of a multifaceted strategy to achieve and sustain universal access to ITNs. A combination of these strategies has been effective for scaling up ITN access.

How long do ITNs last?

However, in reality, the lifespan of ITNs may actually be closer to two rather than 3 years [ 30, 31, 32, 33 ]. Because of these gaps in coverage, there are still vulnerable households who need replacement ITNs between distributions.

How many regions are there in SNP4?

SNP4 scaled up the programme from three regions in 2015 to seven regions in 2016 and SNP5 targeted 14 regions in 2017. The number of classes targeted varied by region in relation to previous distributions. Selection of classes was based on provisional enrollment data from a President’s Office Regional Administration and Local Government (PO-RALG) system (Basic Education Management Information System (BEMIS)) as of June 30, 2017, earlier NetCALC universal coverage modelling, and consultation with NMCP. Engagement and coordination meetings to involve key stakeholders in the implementation of SNP5 were conducted by international stakeholders and the NMCP at the national, regional and district levels. Trainings were also held in the seven regions that had implemented SNP in the previous round (SNP4), as well as the seven new regions.

What is one way sensitivity analysis?

One-way sensitivity analysis testing base-case assumptions on the economic cost per person year of protection from the full provider perspective is shown in Table 4. The base case scenario assumes that one ITN provides 3 years of protection for two people and assumes 100% of nets distributed are being used.

What is ITN use?

ITN use, obtained from population surveys, is defined as the proportion of the population that slept under an ITN the night before the survey. The use:access ratio gives an estimate of the proportion of the population using nets, among those that have access to one within their household. This indicator provides data on the behavioural gap for net use—rather than a gap because not enough nets are available [ 8 ]. The most recent use:access estimates from each country that costs were collected from were used to test the 100% use assumption. Use:access in Tanzania ranged from 0.69 to 1.05 across all regions in 2015 with an average use:access ratio of 0.83, use:access in Ghana ranged from 0.34 to 0.81 across all regions in 2014, with an average of 0.65 [ 47 ]. Between 2006 and 2010, the use:access ratio for almost all regions in Mali increased to above 0.80, and this was maintained through the 2015 survey with a range of 0.98–1.08 [ 47 ].

How much money will be spent on malaria in 2020?

Tracking global malaria spending provides insight into how far the world is from reaching the malaria funding target of $6·6 billion annually by 2020. Because most countries with a high burden of malaria are low income or lower-middle income, mobilising additional government resources for malaria might be challenging.

How many countries were malaria free in 2000?

We estimated domestic malaria spending by source in 106 countries that were malaria-endemic in 2000–16 or became malaria-free after 2000.

image
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 1 2 3 4 5 6 7 8 9